No South Asia events available.
Filter by type and usage:
This report aims to evaluate the effectiveness and fit of open contracting reforms to LMIC contexts and to provide
recommendations on how and when countries should pursue open contracting reforms. This objective was broken
down into the following questions on reform outcomes and reform drivers.
1. How advanced and comprehensive is the legal framework for open contracting? How did it evolve in the last 10-
15 years?
2. To what extent are the laws relating to public procurement transparency and accountability implemented? How
did the comprehensiveness and quality of publicly available government contracting data evolve in the last 10-15
years?
3. What is the political-economic context in which public procurement occurs? Who are the main actors in
government and civil society, what are their power relations and interests? Which actors have driven or blocked
open contracting reform?
4. Which conditions and institutional capacities have facilitated or hindered public procurement transparency
reform?
5. Which reform strategies have proved most successful and unsuccessful in which contexts? What were the
typical time frames and pathways for successful reform that can inform design of future advocacy strategies?
This set of concise guidelines is meant to provide an overview of the procurement process and to provide specific insight into commonly applicable articles and rules in order to enable health professionals to ascertain if the process has been followed properly prior to reaching a decision.
The World Bank has developed a set of procurement indicators that can be used to monitor the implementation of electronic government procurement, or e-GP.
This document describes these WB indicators, and for each indicator identifies:
» what it attempts to measure
» the formula used to calculate its value, where possible
» what constitutes a “good” value for the indicator
The World Health Organization 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. This report also presents, for the first time, spending on primary health care and specific diseases and looks closely at the relationship between spending and service coverage.
Believing that user-centered design was critical to do this well, Wikimedia partnered with Reboot, and together we researched the information and internet needs, habits, and constraints of users in priority countries. Side by-side, Reboot and Wikimedia staff conducted in-depth design research with over 100 diverse users in India and Nigeria. Based on the findings, they identified opportunities for Wikipedia to grow its reach and impact, including through new features, strategies, and partnerships—and through
harnessing the passion and energy of its global community.
Successfully fighting corruption requires widespread public engagement and pressure. But effective engagement doesn’t just happen; it is a creative and constructive process that involves planning strategic activities to inspire people to confront corruption as a major social, economic and political offence and a violation of human rights.
This Transparency International (TI) advocacy guide seeks to assist TI’s National Chapters and other civil society organisations through this process of:
1. Analysing problems, finding solutions and identifying stakeholders;
2. Defining the objectives and other building blocks of an advocacy plan;
3. Assessing risks and reviewing feasibility and sustainability;
4. Planning activities and linking them with resources; and
5. Checking how successful the advocacy plan has been.
“A study of Public Procurement in the Health sector and Availability of Procurement Data” was conducted for mapping the existing procurement related laws, Gaps, issues and challenges of EGP and OCDS in Health Sector. The study also aimed for assessment of procurement of selected medicines, vaccines, including cost calculation and price variations.
*